Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline

Alikhan, Raza, Gomez, Keith, Maraveyas, Anthony, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Young, Annie and Thomas, Mari 2024. Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline. British Journal of Haematology 205 (1) , pp. 71-87. 10.1111/bjh.19414

Preview

PDF - Accepted Post-Print Version Download (687kB) | Preview

Abstract

A shared decision on the most appropriate agent for the treatment of cancer-associated thrombosis should consider the following factors, which should be reassessed as patients continue along their cancer care pathway: risk of bleeding; tumour site; suitability of oral medications; potential for drug–drug interactions; and patient preference and values regarding choice of drug. Continuing anticoagulation beyond 6 months in patients with cancer-associated venous thromboembolism and active cancer is recommended.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Publisher:	Wiley
ISSN:	0007-1048
Date of First Compliant Deposit:	14 March 2025
Date of Acceptance:	11 March 2024
Last Modified:	25 Apr 2025 01:45
URI:	https://orca.cardiff.ac.uk/id/eprint/176004

Actions (repository staff only)

Edit Item